Terms ending in 2029
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,377,928 | 3-Aminosulfonyl Substituted Indole Derivatives and Methods of Use Thereof In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,557,798 | Macrocyclic Heterocyclic Aspartyl Protease Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,501,773 | 4-Fluoro-Piperidine T-Type Calcium Channel Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,786,329 | Process for Preparing Ester Oxazolidine Compounds and Their Conversion to Florfenicol In force · Medium confidence | Intervet Inc. | In force | Medium confidence | |
| US 7,964,739 | Process for the Preparation of Asenapine and Intermediate Products Used in Said Process In force · High confidence | Forest Laboratories Holdings Limited | In force | High confidence | |
| US 8,168,658 | Inhibitors of Histone Deacetylase In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,293,883 | Engineered ANTI-IL-23P19 Antibodies In force · High confidence | Merck Sharp & Dohme Corp. | In force | High confidence | |
| US 8,138,219 | Tryptamine Sulfonamides as 5-HT6 Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,198,079 | Synthetic Expression Vectors for Insect Cells In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,022,215 | Fused Pyridone M1 Receptor Positive Allosteric Modulators In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 157 more term ends in 2029 · Pro | |||||
10 of 167 patents shown. Soonest term end first, then patent number.
Pro members see all 167.
159 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.